Using Point of Care Ultrasound to Diagnose Small Bowel Obstruction in Emergency Departments
Contribution of Point of Care Ultrasound by the Emergency Physician to Rule Out the Small Bowel Obstruction: a Diagnostic, Multicenter Study
This study tests whether using ultrasound in the emergency department can help doctors quickly and safely diagnose small bowel obstruction instead of relying on CT scans.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 667 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nantes University Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 18 sites (Clermont-Ferrand, France and 17 other locations) |
| Trial ID | NCT06803628 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of Point of Care Ultrasound (POCUS) in diagnosing Small Bowel Obstruction (SBO) in emergency department patients. Currently, diagnosis relies heavily on abdominal CT scans, which have drawbacks such as radiation exposure and increased costs. The study will assess the diagnostic accuracy of POCUS and its ability to rule out SBO, potentially improving patient management and reducing unnecessary CT scans. Additionally, it will explore the use of Gestalt probability assessments by physicians to evaluate the likelihood of SBO based on clinical presentation.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old presenting to the emergency department with suspected SBO and low to moderate pretest clinical probability.
Not a fit: Patients who are under legal guardianship, pregnant, nursing, or have already had imaging confirming SBO will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could reduce reliance on CT scans, minimizing radiation exposure and healthcare costs for patients with suspected SBO.
How similar studies have performed: Previous studies have shown promising results for POCUS in diagnosing SBO, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Major patient (age \> 18 years old), no upper limit 2. Patient admitted to the ED with suspected SBO (abdominal pain, vomiting, cessation of gas and feces...) 3. Low or moderate pretest Gestalt clinical probability 4. Patient able to understand protocol and express agreement 5. Oral non-opposition given Exclusion Criteria: 1. Patient under legal guardianship 2. Pregnant women 3. Nursing mothers 4. Patient who does not speak or understand French 5. Patient without a health insurance plan 6. Patient who already had imaging confirming the diagnosis 7. Patient who participates simultaneously in any interventional study focused on abdominal pain before POCUS and CT realization
Where this trial is running
Clermont-Ferrand, France and 17 other locations
- Chu Clermont-Ferrand Hopital Gabriel Montpied — Clermont-Ferrand, France, France (Recruiting)
- Ghem Groupe Hospitalier Eaubonne Montmorency Simone Veil — Eaubonne, France, France (Recruiting)
- CHD Vendée — La Roche-sur-Yon, France, France (Recruiting)
- CHD Vendée, Luçon — Luçon, France, France (Recruiting)
- Ap-Hm Hopital La Timone — Marseille, France, France (Recruiting)
- Hôpital Nord — Marseille, France, France (Withdrawn)
- Ghsif Groupe Hospitalier Sud Ile de Franc _ Ch Melun — Melun, France, France (Recruiting)
- CHD Vendée, Montaigu — Montaigu, France, France (Recruiting)
- CHU Nantes — Nantes, France, France (Recruiting)
- Le Confluent — Nantes, France, France (Recruiting)
- CHU CAREMEAU - Nimes — Nîmes, France, France (Recruiting)
- AP-HP Est Parisien _ ST-ANTOINE — Paris, France, France (Recruiting)
- P-HP Paris Centre - COCHIN — Paris, France, France (Recruiting)
- Chru Poitiers — Poitiers, France, France (Recruiting)
- CH MEMORIAL - Saint Lô — Saint-Lô, France, France (Recruiting)
- CH Saint-Nazaire — Saint-Nazaire, France, France (Recruiting)
- Groupe Hospitalier Selestat Obernai (Ghso) — Sélestat, France, France (Recruiting)
- Hopital PURPAN CHU Toulouse — Toulouse, France, France (Recruiting)
Study contacts
- Study coordinator: Philippe LE CONTE Professor LE CONTE, Professor
- Email: philippe.leconte@chu-nantes.fr
- Phone: 0240083934
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.